divalproex sodium

Generic: divalproex sodium

Labeler: ncs healthcare of ky, llc dba vangard labs
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name divalproex sodium
Generic Name divalproex sodium
Labeler ncs healthcare of ky, llc dba vangard labs
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

divalproex sodium 125 mg/1

Manufacturer
NCS HealthCare of KY, LLC dba Vangard Labs

Identifiers & Regulatory

Product NDC 0615-8237
Product ID 0615-8237_9acc51b3-fd1c-48a4-b620-689c38545dd5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078979
Listing Expiration 2026-12-31
Marketing Start 2009-01-23

Pharmacologic Class

Classes
anti-epileptic agent [epc] decreased central nervous system disorganized electrical activity [pe] mood stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 06158237
Hyphenated Format 0615-8237

Supplemental Identifiers

RxCUI
1099596
UNII
644VL95AO6

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name divalproex sodium (source: ndc)
Generic Name divalproex sodium (source: ndc)
Application Number ANDA078979 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 125 mg/1
source: ndc
Packaging
  • 15 CAPSULE in 1 BLISTER PACK (0615-8237-05)
  • 28 CAPSULE in 1 BLISTER PACK (0615-8237-28)
  • 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8237-30) / 5 CAPSULE in 1 BLISTER PACK
  • 30 CAPSULE in 1 BLISTER PACK (0615-8237-39)
source: ndc

Packages (4)

Ingredients (1)

divalproex sodium (125 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9acc51b3-fd1c-48a4-b620-689c38545dd5", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099596"], "spl_set_id": ["388fd4bc-f12f-4e55-a1e7-72aa585519fa"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 CAPSULE in 1 BLISTER PACK (0615-8237-05)", "package_ndc": "0615-8237-05", "marketing_start_date": "20180827"}, {"sample": false, "description": "28 CAPSULE in 1 BLISTER PACK (0615-8237-28)", "package_ndc": "0615-8237-28", "marketing_start_date": "20240419"}, {"sample": false, "description": "6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8237-30)  / 5 CAPSULE in 1 BLISTER PACK", "package_ndc": "0615-8237-30", "marketing_start_date": "20180827"}, {"sample": false, "description": "30 CAPSULE in 1 BLISTER PACK (0615-8237-39)", "package_ndc": "0615-8237-39", "marketing_start_date": "20180827"}], "brand_name": "Divalproex sodium", "product_id": "0615-8237_9acc51b3-fd1c-48a4-b620-689c38545dd5", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0615-8237", "generic_name": "Divalproex sodium", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "125 mg/1"}], "application_number": "ANDA078979", "marketing_category": "ANDA", "marketing_start_date": "20090123", "listing_expiration_date": "20261231"}